Articles by Jane Wan - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jane Wan

Report from Thailand

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.
Apr 1, 2013

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.

Report from India

India's biopharmaceutical industry is valued at $2 billion a year with 20 companies producing biosimilars and 50 products available in the domestic market.
Feb 1, 2013

India's biopharmaceutical industry is valued at $2 billion a year with 20 companies producing biosimilars and 50 products available in the domestic market.

Report from South Korea

The South Korean market is characterized by its aging population and an affluent population. Growth potential is limited as it has evolved to a developed market and industry players expect it to have established regulations.
Dec 1, 2012

The South Korean market is characterized by its aging population and an affluent population. Growth potential is limited as it has evolved to a developed market and industry players expect it to have established regulations.

Report from India

India has enforced stricter patent laws compared to other countries. For a drug to be patentable in India, the invention has to be novel, inventive, and industrially applicable.
Oct 1, 2012

India has enforced stricter patent laws compared to other countries. For a drug to be patentable in India, the invention has to be novel, inventive, and industrially applicable.

Report from Japan

After a series of government reforms, the Japanese pharma market is making a comeback.
Aug 1, 2012

After a series of government reforms, the Japanese pharma market is making a comeback.

ADVERTISEMENT

ADVERTISEMENT

Click here